HomeVSTM • NASDAQ
Verastem Inc
add
$4.16
0.00%
Pre-market:(1.20%)+0.050
$4.21
Closed: Jun 27, 8:49:26 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 44.17M | 57.43% |
Net income | -52.10M | -53.86% |
Net profit margin | — | — |
Earnings per share | -0.79 | 19.39% |
EBITDA | -44.16M | -57.43% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 117.57M | 6.76% |
Total assets | 131.70M | 6.60% |
Total liabilities | 164.13M | 112.28% |
Total equity | -32.43M | — |
Shares outstanding | 54.95M | — |
Price to book | -6.60 | — |
Return on assets | -94.70% | — |
Return on capital | -382.64% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -52.10M | -53.86% |
Cash from operations | -38.68M | -36.63% |
Cash from investing | — | — |
Cash from financing | 67.43M | 7,870.09% |
Net change in cash | 28.75M | 717.25% |
Free cash flow | -24.28M | -29.15% |
Previous close
$4.16
Year range
$2.10 - $9.10
Market cap
228.59M USD
Avg Volume
2.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Headquarters
Website
Employees
78
